Do analysts prefer ICU or ZYXI?

SeaStar Medical currently has a consensus price target of $8.00, suggesting a potential upside of 125.35%. Given SeaStar Medical's stronger consensus rating and higher probable upside, research analysts clearly believe SeaStar Medical is more favorable than Zynex. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SeaStar Medical 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Zynex 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation & earnings, ICU or ZYXI?

Zynex has higher revenue and earnings than SeaStar Medical. SeaStar Medical is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio SeaStar Medical $1.23M 12.73 -$12.15M -$3.91 N/A Zynex $108.20M 0.04 $2.99M -$2.43 N/A

Is ICU or ZYXI more profitable?

Zynex has a net margin of -68.35% compared to SeaStar Medical's net margin of -795.51%. SeaStar Medical's return on equity of -162.75% beat Zynex's return on equity. Company Net Margins Return on Equity Return on Assets SeaStar Medical -795.51% -162.75% -109.89% Zynex -68.35% -804.30% -36.67%

Do analysts rate ZYXI or CTSO?

Cytosorbents has a consensus target price of $107.50, suggesting a potential upside of 2,614.65%. Given Cytosorbents' stronger consensus rating and higher probable upside, analysts plainly believe Cytosorbents is more favorable than Zynex. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zynex 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Cytosorbents 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has higher earnings & valuation, ZYXI or CTSO?

Zynex has higher revenue and earnings than Cytosorbents. Cytosorbents is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Zynex $108.20M 0.04 $2.99M -$2.43 N/A Cytosorbents $37.06M 0.34 -$8.20M -$5.80 N/A

Is ZYXI or CTSO more profitable?

Cytosorbents has a net margin of -48.94% compared to Zynex's net margin of -68.35%. Cytosorbents' return on equity of -431.65% beat Zynex's return on equity. Company Net Margins Return on Equity Return on Assets Zynex -68.35% -804.30% -36.67% Cytosorbents -48.94% -431.65% -41.94%

Do analysts prefer TMDIF or ZYXI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Titan Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Zynex 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is TMDIF or ZYXI more profitable?

Titan Medical has a net margin of 0.00% compared to Zynex's net margin of -68.35%. Titan Medical's return on equity of -82.31% beat Zynex's return on equity. Company Net Margins Return on Equity Return on Assets Titan Medical N/A -82.31% -51.47% Zynex -68.35% -804.30% -36.67%

Do analysts prefer IRIX or ZYXI?

IRIDEX presently has a consensus target price of $3.00, indicating a potential upside of 334.78%. Given IRIDEX's stronger consensus rating and higher possible upside, equities analysts clearly believe IRIDEX is more favorable than Zynex. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score IRIDEX 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Zynex 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher earnings & valuation, IRIX or ZYXI?

Zynex has higher revenue and earnings than IRIDEX. IRIDEX is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio IRIDEX $52.67M 0.23 -$4.44M -$0.20 N/A Zynex $108.20M 0.04 $2.99M -$2.43 N/A

Is IRIX or ZYXI more profitable?

IRIDEX has a net margin of -6.88% compared to Zynex's net margin of -68.35%. IRIDEX's return on equity of 0.00% beat Zynex's return on equity. Company Net Margins Return on Equity Return on Assets IRIDEX -6.88% N/A -12.55% Zynex -68.35% -804.30% -36.67%

Zynex (ZYXI) Competitors

$0.12 0.00 (0.00%)

As of 10/2/2026

Compare

ZYXI vs. ICU, CTSO, TMDIF, NMTC, and IRIX

Should you buy Zynex stock or one of its competitors? Zynex's main competitors and comparable companies include SeaStar Medical (ICU), Cytosorbents (CTSO), Titan Medical (TMDIF), NeuroOne Medical Technologies (NMTC), and IRIDEX (IRIX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Zynex compare to SeaStar Medical?

SeaStar Medical (NASDAQ:ICU) and Zynex (NASDAQ:ZYXI) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, analyst recommendations, risk, profitability, dividends, earnings and media sentiment.

Zynex has higher revenue and earnings than SeaStar Medical. SeaStar Medical is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SeaStar Medical	$1.23M	12.73	-$12.15M	-$3.91	N/A
Zynex	$108.20M	0.04	$2.99M	-$2.43	N/A

1.7% of SeaStar Medical shares are owned by institutional investors. Comparatively, 29.7% of Zynex shares are owned by institutional investors. 0.7% of SeaStar Medical shares are owned by insiders. Comparatively, 49.3% of Zynex shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, SeaStar Medical had 8 more articles in the media than Zynex. MarketBeat recorded 8 mentions for SeaStar Medical and 0 mentions for Zynex. SeaStar Medical's average media sentiment score of 0.22 beat Zynex's score of 0.00 indicating that SeaStar Medical is being referred to more favorably in the media.

Company	Overall Sentiment
SeaStar Medical	Neutral
Zynex	Neutral

SeaStar Medical has a beta of -1.09, indicating that its stock price is 209% less volatile than the broader market. Comparatively, Zynex has a beta of 0.99, indicating that its stock price is 1% less volatile than the broader market.

Zynex has a net margin of -68.35% compared to SeaStar Medical's net margin of -795.51%. SeaStar Medical's return on equity of -162.75% beat Zynex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SeaStar Medical	-795.51%	-162.75%	-109.89%
Zynex	-68.35%	-804.30%	-36.67%

SeaStar Medical currently has a consensus price target of $8.00, suggesting a potential upside of 125.35%. Given SeaStar Medical's stronger consensus rating and higher probable upside, research analysts clearly believe SeaStar Medical is more favorable than Zynex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SeaStar Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Zynex	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Zynex beats SeaStar Medical on 9 of the 16 factors compared between the two stocks.

How does Zynex compare to Cytosorbents?

Zynex (NASDAQ:ZYXI) and Cytosorbents (NASDAQ:CTSO) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, media sentiment, dividends, profitability, valuation and earnings.

In the previous week, Cytosorbents had 3 more articles in the media than Zynex. MarketBeat recorded 3 mentions for Cytosorbents and 0 mentions for Zynex. Zynex's average media sentiment score of 0.00 equaled Cytosorbents'average media sentiment score.

Company	Overall Sentiment
Zynex	Neutral
Cytosorbents	Neutral

Cytosorbents has a consensus target price of $107.50, suggesting a potential upside of 2,614.65%. Given Cytosorbents' stronger consensus rating and higher probable upside, analysts plainly believe Cytosorbents is more favorable than Zynex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zynex	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Cytosorbents	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Zynex has higher revenue and earnings than Cytosorbents. Cytosorbents is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zynex	$108.20M	0.04	$2.99M	-$2.43	N/A
Cytosorbents	$37.06M	0.34	-$8.20M	-$5.80	N/A

Cytosorbents has a net margin of -48.94% compared to Zynex's net margin of -68.35%. Cytosorbents' return on equity of -431.65% beat Zynex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zynex	-68.35%	-804.30%	-36.67%
Cytosorbents	-48.94%	-431.65%	-41.94%

Zynex has a beta of 0.99, indicating that its stock price is 1% less volatile than the broader market. Comparatively, Cytosorbents has a beta of 1.37, indicating that its stock price is 37% more volatile than the broader market.

29.7% of Zynex shares are owned by institutional investors. Comparatively, 32.9% of Cytosorbents shares are owned by institutional investors. 49.3% of Zynex shares are owned by insiders. Comparatively, 7.8% of Cytosorbents shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Cytosorbents beats Zynex on 9 of the 15 factors compared between the two stocks.

How does Zynex compare to Titan Medical?

Titan Medical (NASDAQ:TMDIF) and Zynex (NASDAQ:ZYXI) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, profitability, institutional ownership, earnings, dividends, risk and analyst recommendations.

Titan Medical has a beta of 1.26, indicating that its stock price is 26% more volatile than the broader market. Comparatively, Zynex has a beta of 0.99, indicating that its stock price is 1% less volatile than the broader market.

Titan Medical has a net margin of 0.00% compared to Zynex's net margin of -68.35%. Titan Medical's return on equity of -82.31% beat Zynex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Titan Medical	N/A	-82.31%	-51.47%
Zynex	-68.35%	-804.30%	-36.67%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Titan Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Zynex	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Titan Medical has higher earnings, but lower revenue than Zynex. Zynex is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Titan Medical	$17.63M	0.71	$6.95M	$0.05	2.20
Zynex	$108.20M	0.04	$2.99M	-$2.43	N/A

In the previous week, Titan Medical's average media sentiment score of 0.00 equaled Zynex'saverage media sentiment score.

Company	Overall Sentiment
Titan Medical	Neutral
Zynex	Neutral

0.0% of Titan Medical shares are owned by institutional investors. Comparatively, 29.7% of Zynex shares are owned by institutional investors. 0.0% of Titan Medical shares are owned by company insiders. Comparatively, 49.3% of Zynex shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Titan Medical and Zynex tied by winning 6 of the 12 factors compared between the two stocks.

How does Zynex compare to NeuroOne Medical Technologies?

NeuroOne Medical Technologies (NASDAQ:NMTC) and Zynex (NASDAQ:ZYXI) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, profitability, risk, analyst recommendations, dividends and institutional ownership.

16.1% of NeuroOne Medical Technologies shares are held by institutional investors. Comparatively, 29.7% of Zynex shares are held by institutional investors. 11.8% of NeuroOne Medical Technologies shares are held by company insiders. Comparatively, 49.3% of Zynex shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Zynex has a net margin of -68.35% compared to NeuroOne Medical Technologies' net margin of -71.50%. NeuroOne Medical Technologies' return on equity of -128.12% beat Zynex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NeuroOne Medical Technologies	-71.50%	-128.12%	-86.34%
Zynex	-68.35%	-804.30%	-36.67%

Zynex has higher revenue and earnings than NeuroOne Medical Technologies. NeuroOne Medical Technologies is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NeuroOne Medical Technologies	$12.10M	0.84	-$3.61M	-$0.95	N/A
Zynex	$108.20M	0.04	$2.99M	-$2.43	N/A

In the previous week, NeuroOne Medical Technologies had 7 more articles in the media than Zynex. MarketBeat recorded 7 mentions for NeuroOne Medical Technologies and 0 mentions for Zynex. NeuroOne Medical Technologies' average media sentiment score of 0.72 beat Zynex's score of 0.00 indicating that NeuroOne Medical Technologies is being referred to more favorably in the media.

Company	Overall Sentiment
NeuroOne Medical Technologies	Positive
Zynex	Neutral

NeuroOne Medical Technologies currently has a consensus price target of $7.33, indicating a potential upside of 557.70%. Given NeuroOne Medical Technologies' stronger consensus rating and higher probable upside, analysts clearly believe NeuroOne Medical Technologies is more favorable than Zynex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeuroOne Medical Technologies	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Zynex	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

NeuroOne Medical Technologies has a beta of 0.77, indicating that its share price is 23% less volatile than the broader market. Comparatively, Zynex has a beta of 0.99, indicating that its share price is 1% less volatile than the broader market.

Summary

NeuroOne Medical Technologies and Zynex tied by winning 8 of the 16 factors compared between the two stocks.

How does Zynex compare to IRIDEX?

IRIDEX (NASDAQ:IRIX) and Zynex (NASDAQ:ZYXI) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, risk, valuation, analyst recommendations, media sentiment and institutional ownership.

In the previous week, IRIDEX had 3 more articles in the media than Zynex. MarketBeat recorded 3 mentions for IRIDEX and 0 mentions for Zynex. IRIDEX's average media sentiment score of 0.00 equaled Zynex'saverage media sentiment score.

Company	Overall Sentiment
IRIDEX	Neutral
Zynex	Neutral

IRIDEX has a net margin of -6.88% compared to Zynex's net margin of -68.35%. IRIDEX's return on equity of 0.00% beat Zynex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IRIDEX	-6.88%	N/A	-12.55%
Zynex	-68.35%	-804.30%	-36.67%

IRIDEX presently has a consensus target price of $3.00, indicating a potential upside of 334.78%. Given IRIDEX's stronger consensus rating and higher possible upside, equities analysts clearly believe IRIDEX is more favorable than Zynex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Zynex	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

20.1% of IRIDEX shares are held by institutional investors. Comparatively, 29.7% of Zynex shares are held by institutional investors. 8.6% of IRIDEX shares are held by insiders. Comparatively, 49.3% of Zynex shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Zynex has higher revenue and earnings than IRIDEX. IRIDEX is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IRIDEX	$52.67M	0.23	-$4.44M	-$0.20	N/A
Zynex	$108.20M	0.04	$2.99M	-$2.43	N/A

IRIDEX has a beta of 0.67, indicating that its stock price is 33% less volatile than the broader market. Comparatively, Zynex has a beta of 0.99, indicating that its stock price is 1% less volatile than the broader market.

Summary

IRIDEX beats Zynex on 9 of the 15 factors compared between the two stocks.

Get Zynex News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ZYXI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ZYXI vs. The Competition

Export

Metric	Zynex	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$3.80M	$5.46B	$7.14B	$13.26B
Dividend Yield	N/A	1.79%	2.53%	17.34%
P/E Ratio	-0.05	25.76	274.32	26.20
Price / Sales	0.04	69.14	609.37	88.34
Price / Cash	0.51	32.73	27.22	34.70
Price / Book	0.11	6.04	11.23	6.40
Net Income	$2.99M	$146.97M	$3.49B	$381.07M
7 Day Performance	N/A	-0.95%	-1.68%	-0.65%
1 Month Performance	N/A	-4.28%	-5.97%	-4.51%
1 Year Performance	-91.50%	2.47%	8.11%	1.82%

Zynex Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ZYXI Zynex	N/A	$0.13 flat	N/A	N/A	$3.80M	$108.20M	N/A	770
ICU SeaStar Medical	2.8207 of 5 stars	$3.56 +4.7%	$8.00 +124.7%	-27.7%	$14.98M	$1.23M	N/A	2	News Coverage Gap Down High Trading Volume
CTSO Cytosorbents	3.2335 of 5 stars	$4.00 -0.5%	$107.50 +2,587.5%	-79.4%	$12.67M	$37.06M	N/A	129	Analyst Forecast Gap Down
TMDIF Titan Medical	N/A	$0.11 +6.8%	N/A	-77.1%	$12.59M	$17.63M	N/A	50	Gap Up
NMTC NeuroOne Medical Technologies	3.9607 of 5 stars	$1.09 -16.2%	$7.33 +572.8%	-79.9%	$11.84M	$12.10M	N/A	18	News Coverage Gap Up High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ZYXI) was last updated on 10/5/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Zynex (ZYXI) Competitors

ZYXI vs. ICU, CTSO, TMDIF, NMTC, and IRIX

How does Zynex compare to SeaStar Medical?

Summary

How does Zynex compare to Cytosorbents?

Summary

How does Zynex compare to Titan Medical?

Summary

How does Zynex compare to NeuroOne Medical Technologies?

Summary

How does Zynex compare to IRIDEX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ZYXI vs. The Competition

Zynex Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Zynex (ZYXI) Competitors

ZYXI vs. ICU, CTSO, TMDIF, NMTC, and IRIX

How does Zynex compare to SeaStar Medical?

Which has preferable valuation & earnings, ICU or ZYXI?

Do institutionals and insiders hold more shares of ICU or ZYXI?

Does the media prefer ICU or ZYXI?

Which has more volatility and risk, ICU or ZYXI?

Is ICU or ZYXI more profitable?

Do analysts prefer ICU or ZYXI?

Summary

How does Zynex compare to Cytosorbents?

Does the media favor ZYXI or CTSO?

Do analysts rate ZYXI or CTSO?

Which has higher earnings & valuation, ZYXI or CTSO?

Is ZYXI or CTSO more profitable?

Which has more risk & volatility, ZYXI or CTSO?

Do insiders and institutionals hold more shares of ZYXI or CTSO?

Summary

How does Zynex compare to Titan Medical?

Which has more volatility & risk, TMDIF or ZYXI?

Is TMDIF or ZYXI more profitable?

Do analysts prefer TMDIF or ZYXI?

Which has better valuation and earnings, TMDIF or ZYXI?

Does the media prefer TMDIF or ZYXI?

Do insiders and institutionals have more ownership in TMDIF or ZYXI?

Summary

How does Zynex compare to NeuroOne Medical Technologies?

Do insiders & institutionals believe in NMTC or ZYXI?

Is NMTC or ZYXI more profitable?

Which has better valuation and earnings, NMTC or ZYXI?

Does the media refer more to NMTC or ZYXI?

Do analysts prefer NMTC or ZYXI?

Which has more risk & volatility, NMTC or ZYXI?

Summary

How does Zynex compare to IRIDEX?

Does the media refer more to IRIX or ZYXI?

Is IRIX or ZYXI more profitable?

Do analysts prefer IRIX or ZYXI?

Do institutionals and insiders believe in IRIX or ZYXI?

Which has higher earnings & valuation, IRIX or ZYXI?

Which has more volatility & risk, IRIX or ZYXI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ZYXI vs. The Competition

Zynex Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools